Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Receivables - Other: 2019-2020

Historic Receivables - Other for Revolution Medicines (RVMD) over the last 2 years, with Dec 2020 value amounting to $6.4 million.

  • Revolution Medicines' Receivables - Other fell 26.83% to $6.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $6.4 million, marking a year-over-year decrease of 26.83%. This contributed to the annual value of $6.4 million for FY2020, which is 26.83% down from last year.
  • Per Revolution Medicines' latest filing, its Receivables - Other stood at $6.4 million for FY2020, which was down 26.83% from $8.7 million recorded in FY2019.
  • In the past 5 years, Revolution Medicines' Receivables - Other registered a high of $8.7 million during FY2019, and its lowest value of $6.4 million during FY2020.
  • Moreover, its 2-year median value for Receivables - Other was $7.6 million (2019), whereas its average is $7.6 million.
  • Data for Revolution Medicines' Receivables - Other shows a maximum YoY fell of 26.83% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows Revolution Medicines' Receivables - Other stood at $8.7 million in 2019, then declined by 26.83% to $6.4 million in 2020.